No SBA Protest Review of Approved 8(a) Mentor-Protégé JVs
Client Alert | less than 1 min read | 02.10.12
In Trident, LLC (Jan. 24, 2012), the SBA’s Office of Hearing and Appeals found that SBA area offices have no jurisdiction to review the substance of 8(a) mentor-protégé agreements or joint venture agreements if they have been approved by the SBA’s Office of Business Development before the “final award” of an 8(a) contract. OHA then reversed the size determination made by the area office because it had “no authority (or reason)” to repeat a review of the joint venture agreement for compliance.
Contacts
Insights
Client Alert | 3 min read | 01.21.26
Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement
On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion.
Client Alert | 3 min read | 01.21.26
FedRAMP Proposes Updates to Authorization Process—Six New RFCs Released for Public Comment
Client Alert | 3 min read | 01.20.26
DoW Joins SBA’s Fight Against Alleged Pass-Through Fraud in the 8(a) Program
Client Alert | 3 min read | 01.20.26
Federal Government Challenges Minnesota Law Requiring Affirmative Action in State Government
